(Q34391558)

1 August 2017

1 reference

title

The role of antibiotics in the treatment of infectious diarrhea (English)

1 reference

1 August 2017

0 references

Oldfield EC 3rd

1

1 reference

1 August 2017

Wallace MR

series ordinal

2

1 reference

1 August 2017

publication date

1 September 2001

1 reference

Gastroenterology Clinics of North America

1 August 2017

published in

1 reference

1 August 2017

volume

30

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

817-836

1 reference

Trends in bacterial resistance to fluoroquinolones

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Efficacy and safety of oral rehydration solution with reduced osmolarity in adults with cholera: a randomised double-blind clinical trial. CHOICE study group.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Campylobacter jejuni and the expanding spectrum of related infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Clostridium difficile infection associated with antineoplastic chemotherapy: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Beta-lactam resistance in Aeromonas spp. caused by inducible beta-lactamases active against penicillins, cephalosporins, and carbapenems

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Antimicrobial Resistance of Shigella Isolates in Bangladesh, 1983-1990: Increasing Frequency of Strains Multiply Resistant to Ampicillin, Trimethoprim-Sulfamethoxazole, and Nalidixic Acid

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Emergence of fluoroquinolone resistance in strains of Vibrio cholerae isolated from hospitalized patients with acute diarrhea in Calcutta, India.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Therapy of multidrug-resistant typhoid fever with oral cefixime vs. intravenous ceftriaxone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

EpidemicYersinia enterocoliticaInfection Due to Contaminated Chocolate Milk

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Epidemiology of travelers' diarrhea and relative importance of various pathogens.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Acquisition of Clostridium difficile and Clostridium difficile-associated diarrhea in hospitalized patients receiving tube feeding

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Escherichia coliO157:H7 and the Hemolytic–Uremic Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Quinolone arthropathy in animals versus children

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Yersinia enterocolitica infections in hospitalized patients: the problem of hospital-acquired infections

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

A severe outbreak of Escherichia coli O157:H7--associated hemorrhagic colitis in a nursing home

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Risk factors for the progression of Escherichia coli O157:H7 enteritis to hemolytic-uremic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

In vitro susceptibilities of Plesiomonas shigelloides to 24 antibiotics and antibiotic-beta-lactamase-inhibitor combinations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Chronic diarrhea in infants caused by adherent enteropathogenic Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Two outbreaks of multidrug-resistant Salmonella serotype typhimurium DT104 infections linked to raw-milk cheese in Northern California

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Clinical features, antimicrobial susceptibility and toxin production in Vibrio cholerae O139 infection: comparison with V. cholerae O1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Empirical treatment of severe acute community-acquired gastroenteritis with ciprofloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Treatment of travelers' diarrhea with trimethoprim/sulfamethoxazole and with trimethoprim alone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Five versus three days of ofloxacin therapy for traveler's diarrhea: a placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Efficacy of norfloxacin and doxycycline for treatment of vibrio cholerae 0139 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Quinolone resistance in campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Ciprofloxacin or trimethoprim-sulfamethoxazole as initial therapy for travelers' diarrhea. A placebo-controlled, randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Single Dose Ofloxacin plus Loperamide Compared with Single Dose or Three Days of Ofloxacin in the Treatment of Traveler's Diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Antimicrobial susceptibilities of halophilic vibrios

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Antibiotic treatment of Yersinia enterocolitica septicemia: a retrospective review of 43 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

One-dose treatment with pefloxacin for infection due to multidrug-resistant Shigella dysenteriae type 1 in Burundi

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Aeromonas-related diarrhea in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

1 reference

7 January 2021

Empiric antimicrobial therapy of domestically acquired acute diarrhea in urban adults

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Aeromonas-associated gastroenteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Focal infections due to non-typhi Salmonella in patients with AIDS: report of 10 cases and review

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Emerging quinolone-resistant Salmonella in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Comparative efficacy of cefixime and ampicillin-sulbactam in shigellosis in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Ceftriaxone-resistant Salmonella in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Reduction of Mortality in Chloramphenicol-Treated Severe Typhoid Fever by High-Dose Dexamethasone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Mechanisms and management of antibiotic-associated diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Aeromonas intestinal infections in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Plesiomonas enteric infections in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Antibiotics in Yersinia enterocolitica infections

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Evolving concepts regarding the genus Aeromonas: an expanding Panorama of species, disease presentations, and unanswered questions

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Drug-induced Clostridium difficile-associated disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole. A randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Back to basics in management of Clostridium difficile infections

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Clinical features, epidemiology, and treatment of Plesiomonas shigelloides diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Antimicrobial susceptibility of Plesiomonas shigelloides from patients with diarrhea.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Antibiotic therapy for Salmonella enteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Growth ofEscherichia coliin the presence of trimethoprim-sulfamethoxazole facilitates detection of Shiga-like toxin producing strains by colony blot assay

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Randomised controlled comparison of single-dose ciprofloxacin and doxycycline for cholera caused by Vibrio cholerae 01 or 0139

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Treatment of shigellosis: V. Comparison of azithromycin and ciprofloxacin. A double-blind, randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Increasing antibiotic resistance in clinical isolates of Aeromonas strains in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

In vitro susceptibilities of tropical strains of Aeromonas species from Queensland, Australia, to 22 antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Bacteremia due to non-typhi Salmonella: analysis of 64 cases and review

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Epidemiology of nontyphoidal Salmonella bacteremia during the human immunodeficiency virus epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Double-blind placebo-controlled trial of erythromycin in the treatment of clinical campylobacter infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Yersinia enterocolitica gastroenteritis: a prospective study of clinical, bacteriologic, and epidemiologic features

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Quinolone resistance from a transferable plasmid.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Short-term treatment of traveler's diarrhea with norfloxacin: a double-blind, placebo-controlled study during two seasons

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Seasonal variation in etiology of travelers' diarrhea. Finnish-Moroccan Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Escherichia coli O157:H7

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Disease Due to Enterotoxigenic Escherichia coli in Bangladeshi Adults: Clinical Aspects and a Controlled Trial of Tetracycline

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

An outbreak of multidrug-resistant, quinolone-resistant Salmonella enterica serotype typhimurium DT104.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

In vitro susceptibility of pathogenic Vibrio species to norfloxacin and six other antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

In vitro susceptibilities of Aeromonas hydrophila, Aeromonas sobria, and Aeromonas caviae to 22 antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Ciprofloxacin and loperamide in the treatment of bacillary dysentery

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Emergence of resistant fecal Escherichia coli in travelers not taking prophylactic antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Clinical features of sporadic Yersinia enterocolitica infections in Norway

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Placebo-controlled double-blind evaluation of trimethoprim-sulfamethoxazole treatment of Yersinia enterocolitica gastroenteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Hemolytic-uremic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: clinical and epidemiologic observations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Treatment of traveler's diarrhea with ciprofloxacin and loperamide

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Biotype and antibiotic sensitivity of 100 clinical isolates of Yersinia enterocolitica

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Bacteremia due to Campylobacter species: clinical findings and antimicrobial susceptibility patterns.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Antimicrobial susceptibility of pathogenic Yersinia enterocolitica isolated in Canada from 1972 to 1990.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Randomized, controlled trial of antibiotic therapy for Escherichia coli O157:H7 enteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

The search for a better oral rehydration solution for cholera

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Efficacy of a single dose of furazolidone for treatment of cholera in children

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Clinical significance of primary vs. secondary bacteremia due to nontyphoid Salmonella in patients without AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Epidemic Shigella dysenteriae type 1 in Burundi: panresistance and implications for prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Multidrug-resistant Salmonella typhi: a worldwide epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

A randomized clinical trial to compare the efficacy of erythromycin, ampicillin and tetracycline for the treatment of cholera in children

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Escherichia coli O157:H7 diarrhea in a nursing home: clinical, epidemiological, and pathological findings

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Antimicrobial resistance in organisms causing diarrheal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Antibiotic resistance in Campylobacter strains isolated from animals, foods, and humans in Spain in 1997-1998

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Randomised trial of single-dose ciprofloxacin for travellers' diarrhoea

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Treatment of Shigellosis: IV. Cefixime Is Ineffective in Shigellosis in Adults

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Early treatment with erythromycin of Campylobacter jejuni-associated dysentery in children

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Ciprofloxacin and trimethoprim-sulfamethoxazole versus placebo in acute uncomplicated Salmonella enteritis: a double-blind trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

1 reference

7 January 2021

Antimicrobial susceptibility of Aeromonas species isolated from patients with diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Failure of newer beta-lactam antibiotics for murine Yersinia enterocolitica infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Practical guidelines for the treatment of cholera

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

In vitro activities of lomefloxacin and temafloxacin against pathogens causing diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Why treatment centres failed to prevent cholera deaths among Rwandan refugees in Goma, Zaire

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. Investigation Team.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Escherichia coli O157:H7 infection in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Escherichia coli O157:H7: clinical, diagnostic, and epidemiological aspects of human infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Diabetes mellitus--a newly described risk factor for infection from Salmonella enteritidis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Antibiotics in the Treatment of Gastroenteritis Caused by Enteropathogenic Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

High-level resistance to ciprofloxacin in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Increasing spectrum of resistance in multiresistant Salmonella typhimurium.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Ciprofloxacin-resistant Salmonella typhi and treatment failure

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Failure of ciprofloxacin therapy for invasive nontyphoidal salmonellosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Investigation of multidrug-resistant Salmonella serotype typhimurium DT104 infections linked to raw-milk cheese in Washington State

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Ciprofloxacin versus ceftriaxone in the treatment of multiresistant typhoid fever

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Effect of subinhibitory concentrations of antibiotics on extracellular Shiga-like toxin I.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Successful treatment of diarrheal disease associated with enteroaggregative Escherichia coli in adults infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Empiric treatment of acute diarrheal disease with norfloxacin. A randomized, placebo-controlled study. Swedish Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970212-0

7 January 2021

10.1016/S0889-8553(05)70212-0

Identifiers

DOI

1 reference

1 August 2017

1 reference